Changes in plastic surgery training programs

March 3, 2015- Interviewed by Steven E. Greer, MD

In Part 1 of our interview with the new Chairman of Plastic Surgery at NYU, Eduardo Rodriguez, MD, DDS, explains the changes in training programs now compared to 15-years ago.

How to establish a face transplant team

March 3, 2015- Interviewed by Steven E. Greer, MD

In Part 2 of our interview with Eduardo Rodriguez, MD, DDS, Chairman of Plastic Surgery at NYU, he discusses the new face transplant team that he has assembled, preparing for their first case.

The more we know, the more unnecessary President Bush’s stent seems

October 16, 2013 By Steven E. Greer, MD

A recent short article in an obscure Washington, DC wonky journal triggered national media when it asserted that President George W. Bush’s (43rd President) coronary artery disease was far more dangerous than originally reported in August. NBC Nightly news picked up the story along with numerous other national outlets. The headline was “President Bush had a 95% blockage of the artery”.

When President Bush first received a coronary stent in August, Read more »

Jessie Cheung, MD: FDA scrutiny of dermal fillers

Jessie Cheung, MD, co-director of cosmetic dermatology ant New York University Medical Center, discusses the safety issues raised at the FDA advisory committee on cosmetic dermal fillers

Jessie Cheung, MD: Overview of treating face wrinkles with injections and fillers

December 23, 2008, 9:02 AM ET, Wall Street Journal

http://blogs.wsj.com/health/2008/12/23/economy-be-damned-im-getting-my-botox/tab/print/

Economy Be Damned: I’m Getting My Botox

Patients may be cutting back on some treatments amid the recession, but they’re not letting slimmer pocketbooks take their Botox away from them.

“It’s like comfort food,” says Maralyn Burr of Omaha, Neb., who in June lost her job as a district sales manager for Borders bookstores. With $140,000 in debt from her 22-year-old daughter’s musical education, Burr told the WSJ she’s slashed spending and all but stopped eating out. But she hasn’t given up her Restylane and Botox injections.

She’s not alone. Nearly three-quarters of plastic surgeons responding to a survey this fall said demand has increased or held steady for minimally invasive procedures, including the Botox anti-wrinkle drug, dermal fillers used to plump up lips and smile lines, and skin-smoothing chemical peels, according to the American Society of Plastic Surgeons. At the same time, the survey found a steep drop in demand for plastic surgeries such as breast augmentation and nose reshaping. (See this post from early this year, which took note of a similar pattern.)

Patients may be scrimping on big-ticket procedures but appear to be ponying up a few hundred dollars now and then for injections.

Even so, the companies that make these products aren’t brimming with confidence. Allergan, which makes Botox, cut its 2008 guidance for the product, citing overall “subdued demand,” and Medicis recently has been offering a $100 consumer rebate on its Restylane antiwrinkle products.

Botox Bonus: For more info on the non-surgical alternatives for improving the appearance of your face, see this video with NYU dermatologist Jessie Cheung.